Adar Makovski Silverstein

Adar Makovski Silverstein

Company: Onconova Therapeutics, Inc.

Job title: Director, Corporate Development


Harnessing Multikinase Inhibitors to Weaponize the Next Generation Against Multiple Cancer Indications 2:30 pm

Discussing the potential to treat multiple cancer indications by targeting multiple MOAs with multi-kinases Introducing narazaciclib (ON123300) – discussing its unique MOA, targeting properties and safety profile through preclinical studies Outlining phase 1 study results to date and the future clinical development pathway of narazacliclibRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.